SK282512B6 - Dihydrát 4,10beta-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1- hydroxy-9-oxo-19-nor-cyklopropa[g]tax-11-én-13alfa-yl-(2R,3S)- 3-terc-butoxykarbonylamino-2-hydroxy-3-fenylpropionátu a spôsob jeho prípravy - Google Patents
Dihydrát 4,10beta-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1- hydroxy-9-oxo-19-nor-cyklopropa[g]tax-11-én-13alfa-yl-(2R,3S)- 3-terc-butoxykarbonylamino-2-hydroxy-3-fenylpropionátu a spôsob jeho prípravy Download PDFInfo
- Publication number
- SK282512B6 SK282512B6 SK790-98A SK79098A SK282512B6 SK 282512 B6 SK282512 B6 SK 282512B6 SK 79098 A SK79098 A SK 79098A SK 282512 B6 SK282512 B6 SK 282512B6
- Authority
- SK
- Slovakia
- Prior art keywords
- hydroxy
- cyclopropa
- benzoyloxy
- tax
- oxo
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 150000004683 dihydrates Chemical class 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 150000002576 ketones Chemical class 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 2
- 238000010511 deprotection reaction Methods 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 abstract description 5
- 239000000843 powder Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102100022298 Divergent paired-related homeobox Human genes 0.000 description 4
- 101000902412 Homo sapiens Divergent paired-related homeobox Proteins 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- ZVAFCKLQJCZGAP-WDEREUQCSA-N (2r,3s)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H]([C@@H](O)C(O)=O)C1=CC=CC=C1 ZVAFCKLQJCZGAP-WDEREUQCSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- MSVWUXLRSKRKFZ-IPMKNSEASA-N (2r,4s,5r)-2-(4-methoxyphenyl)-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound C1=CC(OC)=CC=C1[C@@H]1N(C(=O)OC(C)(C)C)[C@@H](C=2C=CC=CC=2)[C@H](C(O)=O)O1 MSVWUXLRSKRKFZ-IPMKNSEASA-N 0.000 description 1
- ZVAFCKLQJCZGAP-UHFFFAOYSA-N 2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)C(O)=O)C1=CC=CC=C1 ZVAFCKLQJCZGAP-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000719 anti-leukaemic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000001599 direct drying Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002411 thermogravimetry Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9514841A FR2742438B1 (fr) | 1995-12-14 | 1995-12-14 | Dihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy- 3-phenylpropionate de 4,10beta-diacetoxy-2alpha-benzoyloxy- 5beta,2o-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa(g)tax-11- ene-13alpha-yle, et son procede de preparation |
| PCT/FR1996/001957 WO1997021695A1 (fr) | 1995-12-14 | 1996-12-09 | DIHYDRATE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4,10β-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA[G]TAX-11-ENE-13α-YLE, ET SON PROCEDE DE PREPARATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK79098A3 SK79098A3 (en) | 1998-11-04 |
| SK282512B6 true SK282512B6 (sk) | 2002-10-08 |
Family
ID=9485512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK790-98A SK282512B6 (sk) | 1995-12-14 | 1996-12-09 | Dihydrát 4,10beta-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1- hydroxy-9-oxo-19-nor-cyklopropa[g]tax-11-én-13alfa-yl-(2R,3S)- 3-terc-butoxykarbonylamino-2-hydroxy-3-fenylpropionátu a spôsob jeho prípravy |
Country Status (37)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102851740A (zh) * | 2011-06-30 | 2013-01-02 | 复旦大学 | 一种氟代多烯紫杉醇晶体及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2698871B1 (fr) * | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
-
1995
- 1995-12-14 FR FR9514841A patent/FR2742438B1/fr not_active Expired - Fee Related
-
1996
- 1996-09-12 UA UA98063068A patent/UA55401C2/uk unknown
- 1996-12-02 UY UY24387A patent/UY24387A1/es not_active IP Right Cessation
- 1996-12-04 TW TW085114946A patent/TW358093B/zh not_active IP Right Cessation
- 1996-12-04 ZA ZA9610200A patent/ZA9610200B/xx unknown
- 1996-12-09 CA CA002236545A patent/CA2236545C/fr not_active Expired - Fee Related
- 1996-12-09 KR KR10-1998-0704420A patent/KR100429330B1/ko not_active Expired - Fee Related
- 1996-12-09 NZ NZ323964A patent/NZ323964A/xx not_active IP Right Cessation
- 1996-12-09 BR BR9611957A patent/BR9611957A/pt not_active IP Right Cessation
- 1996-12-09 ES ES96941720T patent/ES2162123T3/es not_active Expired - Lifetime
- 1996-12-09 WO PCT/FR1996/001957 patent/WO1997021695A1/fr active IP Right Grant
- 1996-12-09 DZ DZ960185A patent/DZ2140A1/fr active
- 1996-12-09 TR TR1998/01087T patent/TR199801087T2/xx unknown
- 1996-12-09 PL PL96327451A patent/PL187613B1/pl not_active IP Right Cessation
- 1996-12-09 HU HU9904048A patent/HU224962B1/hu not_active IP Right Cessation
- 1996-12-09 SK SK790-98A patent/SK282512B6/sk not_active IP Right Cessation
- 1996-12-09 DE DE69614716T patent/DE69614716T2/de not_active Expired - Lifetime
- 1996-12-09 IL IL12476696A patent/IL124766A/xx not_active IP Right Cessation
- 1996-12-09 AU AU11013/97A patent/AU713086C/en not_active Ceased
- 1996-12-09 EA EA199800452A patent/EA000668B1/ru not_active IP Right Cessation
- 1996-12-09 EP EP96941720A patent/EP0876361B1/fr not_active Expired - Lifetime
- 1996-12-09 DK DK96941720T patent/DK0876361T3/da active
- 1996-12-09 RO RO98-01069A patent/RO115880B1/ro unknown
- 1996-12-09 JP JP52179097A patent/JP4059351B2/ja not_active Expired - Fee Related
- 1996-12-09 CN CNA2007101024535A patent/CN101113143A/zh active Pending
- 1996-12-09 CZ CZ19981830A patent/CZ288998B6/cs not_active IP Right Cessation
- 1996-12-09 AT AT96941720T patent/ATE204573T1/de active
- 1996-12-09 PT PT96941720T patent/PT876361E/pt unknown
- 1996-12-12 IN IN2788DE1996 patent/IN185809B/en unknown
- 1996-12-13 TN TNTNSN96157A patent/TNSN96157A1/fr unknown
- 1996-12-13 AR ARP960105668A patent/AR004380A1/es active IP Right Grant
- 1996-12-13 MY MYPI96005258A patent/MY115886A/en unknown
- 1996-12-13 CO CO96065734A patent/CO4810227A1/es unknown
-
1998
- 1998-06-04 NO NO19982561A patent/NO317356B1/no not_active IP Right Cessation
- 1998-06-12 BG BG102535A patent/BG63010B1/bg unknown
- 1998-06-15 OA OA9800085A patent/OA11012A/fr unknown
-
2001
- 2001-08-23 GR GR20010400773T patent/GR3036437T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100377159B1 (ko) | 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법 | |
| CZ125495A3 (en) | Process for preparing clavulanic acid and salt thereof | |
| US4775751A (en) | Process for cephalexin hydrochloride alcoholates | |
| KR100403256B1 (ko) | 결정성n-아세틸뉴라민산유도체및그제조방법 | |
| KR100384773B1 (ko) | 4,10-디아세톡시-2알파-벤조일옥시-5베타,20-에폭시-1,7베타-디히드록시-9-옥소택스-11-엔-13알파-일(2알,3에스)-3-벤조일아미노-2-히드록시-3-페닐프로피오네이트삼수화물의제조방법 | |
| AU711228B2 (en) | Production of cefotaxime and new sodium salts | |
| US4456753A (en) | Process for the manufacture of highly crystalline sodium cefoperazone | |
| SK282512B6 (sk) | Dihydrát 4,10beta-diacetoxy-2alfa-benzoyloxy-5beta,20-epoxy-1- hydroxy-9-oxo-19-nor-cyklopropa[g]tax-11-én-13alfa-yl-(2R,3S)- 3-terc-butoxykarbonylamino-2-hydroxy-3-fenylpropionátu a spôsob jeho prípravy | |
| US6150541A (en) | 4,10-β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-19-norcyclopropa[g]t ax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate dihydrate and its process of preparation | |
| HUT77090A (hu) | Diamino-éterrel képzett diklavulanátsó, eljárás annak előállítására és ezt tartalmazó gyógyászati készítmények | |
| CZ20023723A3 (cs) | Způsob čištění soli klavulanové kyseliny | |
| US20020025938A1 (en) | Macrolide intermediates in the preparation of clarithromycin | |
| MXPA98004604A (en) | Dihydrate (2r, 3s) -3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4, iobeta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-nor- ciclopropa [g] tax-11- en-13alfa-ilo, and its preparation procedure | |
| KR960011779B1 (ko) | 세팔로스포린 결정성 수화물의 신규 제조방법 | |
| HK1113488A (en) | METHOD FOR PREPARING A TAX-11-ENE-13α-YL(2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROP DIHYDRATE | |
| CN1204329A (zh) | (2R,3S)－3－叔丁氧基羰基氨基－2－羟基-3-苯基丙酸紫杉－11－烯－13α－酯二水合物及其制备方法 | |
| WO1992019599A1 (en) | Process for the purification of lofepramine by crystallisation | |
| HK1014187B (en) | Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation | |
| DE1445411A1 (de) | Verfahren zur Herstellung von Yohimbanderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20121209 |